Shetty G, Shetty P, Shetty B, Nanjeshgowda H
Integr Med (Encinitas). 2025; 24(1):10-15.
PMID: 39896828
PMC: 11778323.
Shetty G, Shetty P, Shetty B
Cureus. 2024; 16(4):e57764.
PMID: 38716001
PMC: 11074803.
DOI: 10.7759/cureus.57764.
Chong H, McNamee P, Bachmair E, Martin K, Aucott L, Dhaun N
Rheumatology (Oxford). 2023; 62(12):3819-3827.
PMID: 37018151
PMC: 10691924.
DOI: 10.1093/rheumatology/kead157.
Sci Data. 2022; 9(1):196.
PMID: 35534493
PMC: 9085807.
DOI: 10.1038/s41597-022-01264-y.
Bagherniya M, Darand M, Askari G, Guest P, Sathyapalan T, Sahebkar A
Adv Exp Med Biol. 2021; 1291:251-263.
PMID: 34331695
DOI: 10.1007/978-3-030-56153-6_15.
Central Aspects of Pain in Rheumatoid Arthritis (CAP-RA): protocol for a prospective observational study.
Ifesemen O, McWilliams D, Ferguson E, Wakefield R, Akin-Akinyosoye K, Wilson D
BMC Rheumatol. 2021; 5(1):23.
PMID: 34162435
PMC: 8223274.
DOI: 10.1186/s41927-021-00187-2.
Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China.
Jiang N, Yang P, Liu S, Li H, Wu L, Shi X
Patient Prefer Adherence. 2020; 14:1037-1047.
PMID: 32606620
PMC: 7320887.
DOI: 10.2147/PPA.S232578.
The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologist.
De Cock D, Van der Elst K, Stouten V, Peerboom D, Joly J, Westhovens R
Rheumatol Adv Pract. 2020; 3(2):rkz035.
PMID: 32083241
PMC: 7018614.
DOI: 10.1093/rap/rkz035.
Health status and self-management in patients with inflammatory arthritis-A five-year follow-up study after nurse-led patient education.
Gronning K, Lim S, Bratas O
Nurs Open. 2019; 7(1):326-333.
PMID: 31871717
PMC: 6917950.
DOI: 10.1002/nop2.394.
Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study.
Vittecoq O, Desouches S, Kozyreff M, Nicolau J, Pouplin S, Rottenberg P
BMJ Open. 2019; 9(12):e031467.
PMID: 31857303
PMC: 6937076.
DOI: 10.1136/bmjopen-2019-031467.
Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting.
Camargo M, Barros B, Fulone I, Silva M, Silveira M, de Camargo I
Front Pharmacol. 2019; 10:965.
PMID: 31572173
PMC: 6749844.
DOI: 10.3389/fphar.2019.00965.
The 8-foot up and go test is the best way to assess physical function in the rheumatoid arthritis clinic.
Wilkinson T, Lemmey A, Clayton R, Jones J, OBrien T
Rheumatol Adv Pract. 2019; 2(1):rkx017.
PMID: 31431948
PMC: 6649989.
DOI: 10.1093/rap/rkx017.
Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries.
Kimsey L, Weissman J, Patel A, Drew A, Koehlmoos T, Sparks J
Semin Arthritis Rheum. 2018; 48(5):821-827.
PMID: 30190154
PMC: 6338526.
DOI: 10.1016/j.semarthrit.2018.07.003.
Prostaglandin E2 and IL-23 interconnects STAT3 and RoRγ pathways to initiate Th17 CD4 T-cell development during rheumatoid arthritis.
Samuels J, Holland L, Lopez M, Meyers K, Cumbie W, McClain A
Inflamm Res. 2018; 67(7):589-596.
PMID: 29713730
PMC: 6071319.
DOI: 10.1007/s00011-018-1153-8.
The effectiveness of therapeutic shoes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Tenten-Diepenmaat M, van der Leeden M, Vliet Vlieland T, Roorda L, Dekker J
Rheumatol Int. 2018; 38(5):749-762.
PMID: 29556705
DOI: 10.1007/s00296-018-4014-4.
Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial.
Martin N, Ibrahim F, Tom B, Galloway J, Wailoo A, Tosh J
Trials. 2017; 18(1):591.
PMID: 29221496
PMC: 5723045.
DOI: 10.1186/s13063-017-2330-8.
Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis.
Helmy H, El-Sahar A, Sayed R, Shamma R, Hamed Salama A, Elbaz E
Int J Nanomedicine. 2017; 12:7015-7023.
PMID: 29026298
PMC: 5626385.
DOI: 10.2147/IJN.S147738.
Doctors' preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment.
Kuijper T, Folmer R, Stolk E, Hazes J, Luime J
Arthritis Res Ther. 2017; 19(1):78.
PMID: 28446212
PMC: 5405491.
DOI: 10.1186/s13075-017-1287-z.
Hand exercises for patients with rheumatoid arthritis: an extended follow-up of the SARAH randomised controlled trial.
Williamson E, McConkey C, Heine P, Dosanjh S, Williams M, Lamb S
BMJ Open. 2017; 7(4):e013121.
PMID: 28404610
PMC: 5775458.
DOI: 10.1136/bmjopen-2016-013121.
Certolizumab in the long-term treatment of rheumatoid arthritis.
Khan A, Scott D
Open Access Rheumatol. 2011; 3:63-71.
PMID: 27790005
PMC: 5074781.
DOI: 10.2147/OARRR.S14556.